Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor.
Wagner
Teresa E
TE
Department of Internal Medicine, University of Washington, Seattle, Washington, USA.
Huseby
Eric S
ES
Huseby
Jon S
JS
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000175:diagnosis* / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004751:Enteritis / Q000175:diagnosis / Q000382:microbiology; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D014385:Tuberculosis, Gastrointestinal / Q000175:diagnosis*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab